Jeroen de Jong

4.6k citations

77 papers · 2.5k indexed · h-index 27

Surgery top 5%
Molecular Biology top 10%
Pulmonary and Respiratory Medicine top 5%
Oncology top 5%
Genetics top 10%

Co-authors: Leendert H. J. Looijenga Henk G. van der Poel J. Wolter Oosterhuis Hans Stoop Rosa S. Djajadiningrat Simon Horenblas Ekaterina S. Jordanova Wilbert Zwart
Topics: Prostate Cancer Diagnosis and Treatment (19 papers)Prostate Cancer Treatment and Research (15 papers)Urologic and reproductive health conditions (12 papers)
Cited by: Surgery Pulmonary and Respiratory Medicine Reproductive Medicine
Journals: Nature CommunicationsSHILAP Revista de lepidopterologíaCancer Research
Partner nations: Netherlands United States Germany

In The Last Decade

Jeroen de Jong

76 papers receiving 2.4k citations

Peers

Countries citing papers authored by Jeroen de Jong

Since Specialization

Citations

This map shows the geographic impact of Jeroen de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeroen de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeroen de Jong more than expected).

Fields of papers citing papers by Jeroen de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeroen de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeroen de Jong. The network helps show where Jeroen de Jong may publish in the future.

Co-authorship network of co-authors of Jeroen de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Jeroen de Jong. A scholar is included among the top collaborators of Jeroen de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeroen de Jong. Jeroen de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of a fast and automated DNA identification line 2022 ·Forensic Science International Genetics ·Corina C.G. Benschop,(unknown),Jord H.A. Nagel,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Rolf J.F. Ypma,Jeroen de Jong,Alexander L.J. Kneppers	6
2	Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor 2021 ·Frontiers in Immunology ·(unknown),Hielke M. de Vries,Sarah R. Ottenhof,Ingrid Hofland,Annegien Broeks,Jeroen de Jong,Elise M. Bekers,Simon Horenblas,Renée X. de Menezes,Ekaterina S. Jordanova,Oscar R. Brouwer	6
3	Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer 2019 ·European Journal of Surgical Oncology ·Laura S. Mertens,(unknown),Akash Mehta,(unknown),Jeroen de Jong,Henk Boot,Simon Horenblas,Michiel S. van der Heijden,L. Moonen,Arend G. J. Aalbers,Wim Meinhardt,Bas W.G. van Rhijn	16
4	Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Clarize M. de Korne,Esther Wit,Jeroen de Jong,Renato A. Valdés Olmos,Tessa Buckle,Fijs W. B. van Leeuwen,Henk G. van der Poel	17
5	DNAxs/DNAStatistX: Development and validation of a software suite for the data management and probabilistic interpretation of DNA profiles 2019 ·Forensic Science International Genetics ·Corina C.G. Benschop,Jerry Hoogenboom,(unknown),(unknown),(unknown),(unknown),(unknown),Klaas Slooten,Jord H.A. Nagel,(unknown),(unknown),(unknown),Jeroen de Jong,(unknown),Titia Sijen,Alexander L.J. Kneppers	40
6	A prediction model relating the extent of intraoperative fascia preservation to erectile dysfunction after nerve-sparing robot-assisted radical prostatectomy 2018 ·Journal of Robotic Surgery ·Gijs H. KleinJan,Karolina Sikorska,Clarize M. de Korne,Oscar R. Brouwer,Tessa Buckle,Corinne Tillier,(unknown),Jeroen de Jong,Fijs W. B. van Leeuwen,Henk G. van der Poel	8
7	Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy 2018 ·European Radiology ·(unknown),Ghazaleh Ghobadi,Henk G. van der Poel,Jeroen de Jong,Stijn W. T. P. J. Heijmink,Ivo G. Schoots,Iris Walraven,Petra J. van Houdt,(unknown),Floris J. Pos,Uulke A. van der Heide	12
8	Spectral sensing for tissue diagnosis during lung biopsy procedures: The importance of an adequate internal reference and real-time feedback 2016 ·Lung Cancer ·Jarich W. Spliethoff,Lisanne L. de Boer,Mark A. Meier,Warner Prevoo,Jeroen de Jong,Torre M. Bydlon,Henricus J. C. M. Sterenborg,Jacobus A. Burgers,Benno H. W. Hendriks,T.J.M. Ruers	10
9	Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Gijs H. KleinJan,Nynke S. van den Berg,Jeroen de Jong,Esther Wit,(unknown),Erik Vegt,Henk G. van der Poel,Fijs W. B. van Leeuwen	35
10	Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Nikolaos Grivas,Esther Wit,Floris J. Pos,Jeroen de Jong,Erik Vegt,Axel Bex,Kees Hendricksen,Simon Horenblas,Gijs H. KleinJan,Bas van Rhijn,Henk G. van der Poel	15
11	Histopathology-derived modeling of prostate cancer tumor control probability: Implications for the dose to the tumor and the gland 2016 ·Radiotherapy and Oncology ·Ghazaleh Ghobadi,Jeroen de Jong,(unknown),Baukelien van Triest,Henk G. van der Poel,Conchita Vens,Uulke A. van der Heide	12
12	Gross tumor volume and clinical target volume in prostate cancer: How do satellites relate to the index lesion 2015 ·Radiotherapy and Oncology ·(unknown),Baukelien van Triest,Ghazaleh Ghobadi,Greetje Groenendaal,Jeroen de Jong,Henk G. van der Poel,Uulke A. van der Heide	14
13	Androgen receptor profiling predicts prostate cancer outcome 2015 ·EMBO Molecular Medicine ·Suzan Stelloo,Ekaterina Nevedomskaya,Henk G. van der Poel,Jeroen de Jong,Geert J. van Leenders,Guido Jenster,Lodewyk F.A. Wessels,Andries M. Bergman,Wilbert Zwart	65
14	Optimisation of Fluorescence Guidance During Robot-assisted Laparoscopic Sentinel Node Biopsy for Prostate Cancer 2014 ·European Urology ·Gijs H. KleinJan,Nynke S. van den Berg,Oscar R. Brouwer,Jeroen de Jong,Cenk Acar,Esther Wit,Erik Vegt,Vincent van der Noort,Renato A. Valdés Olmos,Fijs W. B. van Leeuwen,Henk G. van der Poel	82
15	Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory 2008 ·International Journal of Andrology ·Niels J. van Casteren,Jeroen de Jong,Hans Stoop,Ewout W. Steyerberg,Esther W. de Bekker‐Grob,Gert R. Dohle,J. Wolter Oosterhuis,Leendert H. J. Looijenga	30
16	Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications 2008 ·The Journal of Pathology ·Jeroen de Jong,Hans Stoop,(unknown),(unknown),(unknown),Martine de Boer,Remko Hersmus,Philippa T. K. Saunders,(unknown),J. Wolter Oosterhuis,Leendert H. J. Looijenga	183
17	Further characterization of the first seminoma cell line TCam‐2 2007 ·Genes Chromosomes and Cancer ·Jeroen de Jong,Hans Stoop,Ad Gillis,Remko Hersmus,Ruud J. H. L. M. van Gurp,Gert‐Jan M. van de Geijn,Ellen van Drunen,H. Berna Beverloo,Dominik T. Schneider,Jon Sherlock,John Baeten,Sohei Kitazawa,E J van Zoelen,Kees van Roozendaal,J. Wolter Oosterhuis,Leendert H. J. Looijenga	121
18	OCT4: biological functions and clinical applications as a marker of germ cell neoplasia 2006 ·The Journal of Pathology ·Liang Cheng,(unknown),Paolo Cossu‐Rocca,(unknown),Gregory T. MacLennan,Jeroen de Jong,Antonio López-Beltrán,Rodolfo Montironi,Leendert H. J. Looijenga	198
19	Diagnostic value of OCT3/4 for pre‐invasive and invasive testicular germ cell tumours 2005 ·The Journal of Pathology ·Jeroen de Jong,Hans Stoop,Gert R. Dohle,Chris H. Bangma,Mike Kliffen,(unknown),Martin J. van den Bent,Johan M. Kros,J. Wolter Oosterhuis,Leendert H. J. Looijenga	123
20	Determinants of innovative ability 2001 ·RePEc: Research Papers in Economics ·Jeroen de Jong,Ron Kemp,(unknown)	2

About Jeroen de Jong

Jeroen de Jong is a scholar working on Instrumentation, Pulmonary and Respiratory Medicine and Rheumatology, having authored 77 papers that have together received 2.5k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (15 papers) and Urologic and reproductive health conditions (12 papers). The work is most often cited by research in Surgery (1.1k citations), Pulmonary and Respiratory Medicine (716 citations) and Reproductive Medicine (183 citations). Jeroen de Jong has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Leendert H. J. Looijenga, Henk G. van der Poel, J. Wolter Oosterhuis, Hans Stoop, Rosa S. Djajadiningrat, Simon Horenblas, Ekaterina S. Jordanova, Wilbert Zwart, W. Bergman and Andries M. Bergman. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact